Alpha 2.0
Login Register
» Authors » Henriette Bretschneider

Henriette Bretschneider

Explore the profile of Henriette Bretschneider including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 67
Followers 0
Related Specialties
Biomedical Engineering
Biochemistry
Molecular Biology
Top 10 Co-Authors
Corina Vater
Stefan Zwingenberger
Michael Gelinsky
Klaus-Peter Gunther
Anja Lode
Mandy Quade
Stefan Rammelt
Theresa Schildberg
Juliane Rauh
Maik Stiehler
Published In
Int J Mol Sci
Stem Cell Res
J Biomed Mater Res B Appl Biomater
Arch Orthop Trauma Surg
PLoS One
Affiliations
Soon will be listed here.
Recent Articles
1.
Two-Year Results of Injectable Matrix-Associated Autologous Chondrocyte Transplantation in the Hip Joint: Significant Improvement in Clinical and Radiological Assessment
Riedl M, Bretschneider H, Dienst M, Gunther K, Landgraeber S, Schroder J, et al.
J Clin Med . 2023 Sep; 12(17). PMID: 37685535
Purpose: Articular cartilage defects are a prevalent consequence of femoroacetabular impingement (FAI) in young active patients. In accordance with current guidelines, large chondral lesions of the hip joint over 2...
2.
Impact of customized add-on nighttime bracing in full-time brace treatment of adolescent idiopathic scoliosis
Bretschneider H, Bernstein P, Disch A, Seifert J
PLoS One . 2023 Jan; 18(1):e0278421. PMID: 36701318
Study Design: Retrospective cohort study. Objective: Bracing is an accepted standard therapy for idiopathic scoliosis at Cobb angle ranges between 25° and 40°. However, it is unclear, if a specifically...
3.
Combined application of BMP-2 and naturally occurring bioactive factor mixtures for the optimized therapy of segmental bone defects
Vater C, Hetz M, Quade M, Lode A, Gelinsky M, Rammelt S, et al.
Acta Biomater . 2022 Dec; 157:162-174. PMID: 36481501
Critical bone defects are the result of traumatic, infection- or tumor-induced segmental bone loss and represent a therapeutic problem that has not been solved by current reconstructive or regenerative strategies...
4.
Treatment of Critical Size Femoral Bone Defects with Biomimetic Hybrid Scaffolds of 3D Plotted Calcium Phosphate Cement and Mineralized Collagen Matrix
Culla A, Vater C, Tian X, Bolte J, Ahlfeld T, Bretschneider H, et al.
Int J Mol Sci . 2022 Mar; 23(6). PMID: 35328820
To treat critical-size bone defects, composite materials and tissue-engineered bone grafts play important roles in bone repair materials. The purpose of this study was to investigate the bone regenerative potential...
5.
Dose-Dependent Effects of a Novel Selective EP Prostaglandin Receptor Agonist on Treatment of Critical Size Femoral Bone Defects in a Rat Model
Vater C, Mehnert E, Bretschneider H, Bolte J, Findeisen L, Matuszewski L, et al.
Biomedicines . 2021 Nov; 9(11). PMID: 34829941
Difficulties in treating pseudarthrosis and critical bone defects are still evident in physicians' clinical routines. Bone morphogenetic protein 2 (BMP-2) has shown promising osteoinductive results but also considerable side effects,...
6.
Accelerate postoperative management after scoliosis surgery in healthy and impaired children: intravenous opioid therapy versus epidural therapy
Dinter K, Bretschneider H, Zwingenberger S, Disch A, Osmers A, Vicent O, et al.
Arch Orthop Trauma Surg . 2021 Jul; 143(1):301-309. PMID: 34302521
Purpose: Postoperative pain is a major concern following scoliosis surgery. CEA (continuous epidural analgesia) is established in postoperative pain therapy as well as intravenous patient-controlled analgesia (IV-PCA). The purpose of...
7.
Chemotactic and Angiogenic Potential of Mineralized Collagen Scaffolds Functionalized with Naturally Occurring Bioactive Factor Mixtures to Stimulate Bone Regeneration
Bretschneider H, Quade M, Lode A, Gelinsky M, Rammelt S, Vater C
Int J Mol Sci . 2021 Jun; 22(11). PMID: 34072505
To develop cost-effective and efficient bone substitutes for improved regeneration of bone defects, heparin-modified mineralized collagen scaffolds were functionalized with concentrated, naturally occurring bioactive factor mixtures derived from adipose tissue,...
8.
Characterization of Naturally Occurring Bioactive Factor Mixtures for Bone Regeneration
Bretschneider H, Quade M, Lode A, Gelinsky M, Rammelt S, Zwingenberger S, et al.
Int J Mol Sci . 2020 Feb; 21(4). PMID: 32093051
In this study, the bone-regenerative potential of bioactive factors derived from adipose tissue, platelet-rich plasma (PRP) and conditioned medium from hypoxia-treated human telomerase immortalized bone-marrow-derived mesenchymal stem cells (hTERT-MSC) was...
9.
Evaluation of topographical and chemical modified TiAl6V4 implant surfaces in a weight-bearing intramedullary femur model in rabbit
Bretschneider H, Mettelsiefen J, Rentsch C, Gelinsky M, Link H, Gunther K, et al.
J Biomed Mater Res B Appl Biomater . 2019 Aug; 108(3):1117-1128. PMID: 31407488
For cementless total joint replacement implants, the biological response to physicochemical surface characteristics is crucial for their success that depends on fixation by newly formed bone. In this study, the...
10.
Arthroscopic matrix-associated, injectable autologous chondrocyte transplantation of the hip: significant improvement in patient-related outcome and good transplant quality in MRI assessment
Bretschneider H, Trattnig S, Landgraeber S, Hartmann A, Gunther K, Dienst M, et al.
Knee Surg Sports Traumatol Arthrosc . 2019 Apr; 28(4):1317-1324. PMID: 30993353
Purpose: Acetabular chondral lesions are common in patients with FAI. For large full-thickness cartilage defects, arthroscopic matrix-associated autologous chondrocyte transplantation (MACT) using an injectable in situ crosslinking product is an...